Drug Database
PR

prothrombin complex (Cofact)

✓ Approved

Prothya Biosolutions · F2 · Cell-based Therapies

What is prothrombin complex?

prothrombin complex is a cell-based therapies developed by Prothya Biosolutions. It is approved for therapeutic indications via injectable (others) or intravenous (iv).

Drug Profile

Brand NamesCofact
CompanyProthya Biosolutions
Drug ClassCell-based Therapies
Molecular TargetF2, F7, F9, F10
RouteInjectable (Others), Intravenous (IV)
StatusApproved

Mechanism of Action

Molecular Targets

prothrombin complex acts on 4 molecular targets:

F2coagulation factor II, thrombin (THPH1, PT)
F7coagulation factor VII (SPCA)
F9coagulation factor IX (P19, F9 p22)
F10coagulation factor X (FXA, FX)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

prothrombin complex is developed for 2 unique indications across 1 therapeutic area.

Therapeutic AreaConditionPhase
Vascular disordersExtravasation blood✓ Approved
Vascular disordersHaemorrhage✓ Approved

Related Research Articles

PubMedAnalytical chemistry2026-11-11

LNA Blocker-Enhanced Multiplex Chip-Based Digital PCR for Ultrasensitive Quantification of Liver-Specific DNA Methylation in Plasma.

Lan Yanping Y, Yang Xin X, Chen Tianbin T, Huang Haixiong H et al.

Sensitive and selective quantification of rare methylated DNA in plasma remains a major analytical challenge. For methylation targets located in CpG-sparse regions, bisulfite conversion produces only subtle sequence differences between methylated and unmethylated alleles, thereby hindering selective amplification. Here, we report a blocker-enhanced multiplex chip-based digital PCR (cdPCR) strategy for the absolute quantification of liver-specific DNA methylation in plasma. The assay incorporates Locked Nucleic Acid (LNA)-modified blockers to selectively suppress unmethylated background templates, thereby enhancing single-base mismatch discrimination after bisulfite conversion. Seven liver-specific methylation sites within TBX15 were selected and organized into two quadruplex cdPCR panels together with an internal reference gene, enabling multiplex partition-level quantification. The platform achieved a limit of detection of 1 copy/μL, a limit of quantification of 0.2% methylation fraction, and excellent linearity over 1-10,000 copies/μL. In the primary cohort and independent external cohorts comprising 815 plasma samples, the resulting methylation profiles were used to develop diagnostic models using extreme gradient boosting (XGBoost) and logistic regression. The XGBoost model distinguished hepatocellular carcinoma from cirrhosis with an AUC of 0.881 in the test set and retained strong performance in early-stage and seronegative disease, outperforming alpha-fetoprotein and des-gamma-carboxy prothrombin. Additional disease-control and pan-cancer cohorts supported the specificity of the methylation-based models. These results demonstrate that coupling LNA-mediated background suppression with chip-based digital partitioning enables selective and sensitive plasma methylation analysis and provides a practical analytical framework for low-abundance nucleic acid detection.

PubMedThe Journal of cell biology2026-11-11

Heat shock induces assembly of a protein complex that activates yeast SAPKs Mpk1 and Hog1.

Liu Li L, Levin David E DE

Stress-activated protein kinases (SAPKs) respond to a wide variety of stressors. The Saccharomyces cerevisiae SAPK Mpk1 (Slt2) is a well-characterized component of the cell wall integrity (CWI) signaling pathway, which responds to physical and chemical challenges to the cell wall. We find here that Mpk1 is activated by heat shock (HS) through both a "top-down" pathway that activates its MEK and a "lateral" pathway that does not require regulation of the MEK by a MEKK, and which appear to be additive. The lateral pathway requires active SAPK Hog1 and the formation of a protein complex, named here the CWI HS complex. Hog1 is transiently recruited to the complex and is activated therein. Release of Hog1 from the complex requires its catalytic activity, suggesting that it phosphorylates one or more targets while associated with the complex resulting in the activation of Mpk1 and release of Hog1. These results add to the diversity of intracellular mechanisms by which SAPKs are activated.

PubMedJournal of tropical medicine2026-11-11

Therapeutic Potential of Ocimum basilicum in Diabetes-Malaria Comorbidity: Evidence From Parasitemia, Biochemical, and Coagulation Outcomes in Mice.

Ayodele Opeyemi Oluwayemisi OO, Oyerinde Olawunmi Rashidat OR, Bello Oluwatosin Nancy ON, Adeigbe Daniel Gbolahan DG et al.

Diabetes-malaria comorbidity presents a significant therapeutic challenge in endemic regions, as both conditions synergistically impair hepatic and renal function and lack targeted dual-action treatments. Despite the reported antidiabetic and antiplasmodial properties of Ocimum basilicum (OCB), its efficacy in the concurrent management of these diseases remains unexplored. This study therefore evaluated the therapeutic potential of the hydromethanol extract of OCB on parasitemia, biochemical markers of organ function, inflammatory cytokines, and coagulation parameters in a murine model of diabetes-malaria comorbidity. Fifty-six male mice were divided into eight groups (n = 7): control, diabetes only, malaria only, diabetes + malaria, malaria + OCB, diabetes + OCB, diabetes + malaria + OCB, and diabetes + malaria + metformin. Diabetes was induced by streptozotocin (40 mg/kg, i.p., for 5 consecutive days), followed by inoculation with Plasmodium berghei. Parasitemia was quantified by Giemsa-stained thin blood films; fasting blood glucose (FBG), serum creatinine, urea, alanine aminotransferase (ALT), aspartate aminotransferase (AST), TNF-α, interleukin-6 (IL-6), activated partial thromboplastin time, and prothrombin time were measured. The plant extract was profiled for phytochemicals using gas chromatography-mass spectrometry (GC-MS). OCB significantly reduced parasitemia relative to untreated infected controls (p < 0.05). In comorbid animals, OCB lowered FBG by 33.22%, creatinine by 70.58%, and urea by 26.32% compared with the untreated comorbid group. Hepatic enzyme activities (ALT and AST) were reduced more effectively by OCB than by metformin, indicating hepatoprotective activity. IL-6 levels were also significantly suppressed (p < 0.01), while TNF-α and coagulation parameters remained largely unchanged. The GC-MS analysis identified forty-three bioactive compounds, with predominant compounds including gamma-sitosterol, 9,12-octadecadienoic acid, n-hexadecanoic acid, oleic acid, and N-methyl-1-adamantane acetamide. These findings demonstrate that OCB exerts antiplasmodial, antihyperglycemic, and organ-protective effects in diabetes-malaria comorbidity, highlighting its potential as a source of phytopharmaceutical agents for the integrated management of these co-occurring diseases.

PubMedAnalytical chemistry2026-11-11

Natural AIE Probe Screening and Application in Complex Samples Based on Biological Aggregation-Triggered In Situ Luminescence.

Zhang Shuxian S, Yuan Hui H, Yang Lingling L, Fan Xiaoxuan X et al.

The occurrence of thromboembolic diseases is closely related to the generation of biological aggregates mediated by thrombin, and the detection and regulation of its activity are crucial for research in this field. Here, an aggregate-responsive method was proposed and validated based on biological aggregation-triggered in situ luminescence, enabling the screening of natural AIE (aggregation-induced emission) probes, thrombin activity assay, and thrombin inhibitor discovery in complex samples. The results demonstrated that thrombin-induced fibrin aggregation can activate the in situ luminescence of AIE molecules in complex samples. By combining chromatography and mass spectrometry techniques, berberine was identified as a natural compound with significant AIE effects. Quantum chemical calculations simulated the molecular basis of its recognition and emission within the aggregated microenvironment. A visual sensing method for detecting thrombin activity in complex systems has been developed based on the AIE effect. This method successfully demonstrated that the extracts of taxilli herba and notoginseng radix et rhizoma contain effective ingredients that can inhibit thrombin activity. In addition, a computer-mediated virtual screening technique was developed for efficient analysis of active monomers in the candidate extracts. This study indicated that thrombin-mediated biological aggregates can be used for efficient discovery of AIE molecules in complex samples, as well as for efficient discovery of anticoagulant candidate compound.

PubMedFrontiers in plant science2026-11-11

Large-scale organellar genomics reveals maternal evolutionary history and dynamism in the wolfberries.

Yin Yue Y, Wang Luyao L, An Wei W, Bai Xiaorong X et al.

The organellar genomic diversity and maternal evolutionary history of the Lycium complex remain incompletely understood. We compared organellar genomes from 201 accessions, with dense sampling of L. barbarum and L. ruthenicum plus representative relatives. A single L. ruthenicum mitogenome was assembled de novo and used as the reference for comparisons of 186 LR and LB-complex accessions. Plastome analyses resolved seven maternal genetic clusters and identified patterns consistent with complex maternal ancestry within the red wolfberry complex. However, plastid data alone cannot distinguish hybridization, introgression, and incomplete lineage sorting. All 201 plastomes retained a conserved quadripartite structure and 79 unique protein-coding genes. Illumina depth profiles identified a candidate 5.5-kb structural difference with strongly reduced coverage in the LB representative. The corresponding reference interval contains orf27, orf92, and orf93. This depth-supported interval defines a candidate mitochondrial region but does not establish its exact molecular configuration or biological function. This organellar resource provides a framework for testing evolutionary hypotheses and supporting wolfberry germplasm research.

PubMedInternational journal of language & communication disorders2026-11-11

RETRACTION: The Understanding of Complex Syntax in Children From 5 to 9 Years, Using a Novel Assessment Approach - The Test of Complex Syntax- Electronic (TECS-E).

P. Frizelle, A. Oliveira-Buckley, T. Biancone, J. Oliveira, P. Fletcher, D.V.M. Bishop, and C. McKean, "The Understanding of Complex Syntax in Children From 5 to 9 Years, Using a Novel Assessment Approach - The Test of Complex Syntax- Electronic (TECS-E)," International Journal of Language & Communication Disorders 60, no. 4 (2025): e70079, https://doi.org/10.1111/1460-6984.70079. The above article, published online on 10 July 2025 in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the authors; the journal Editors-in-Chief, Jill Titterington and Clare McCann; the Royal College of Speech and Language Therapists; and John Wiley & Sons Ltd. Following publication, concerns were raised on PubPeer regarding statistical errors in the article and those concerns were addressed by the authors [1]. The authors contacted the editors to request retraction, confirming the following errors: inconsistencies in the reported sample sizes; incorrect p-values for the correlation analyses; and incorrect degrees of freedom reported for the ANOVA. The authors agree with the PubPeer comments that the multiple testing is likely to lead to false positives, and that the conclusions are too strong. While the main effects of the paper were correct, they note that the interactions are nonsignificant when the analyses are properly specified. Due to these errors, the article must be retracted.​ A revised version is forthcoming. References [1] Hydrogenophaga pseudoflava and Dorothy V.M. Bishop, "The Understanding of Complex Syntax in Children From 5 to 9 Years, Using a Novel Assessment Approach - The Test of Complex Syntax- Electronic (TECS-E)," PubPeer, 2026, https://pubpeer.com/publications/E4FD07BFB35C4A690778A149A304DF.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about prothrombin complex